SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sresta Natural Bioproducts files DRHP with SEBI for Rs 500 crore IPO

12 Jan 2022 Evaluate

Sresta Natural Bioproducts has filed draft red herring prospectus (DRHP) with the market regulator Securities and Exchange Board of India (SEBI) to raise up to Rs 500 crore through an initial public offering (IPO). The equity shares of the company are proposed to be listed on BSE and NSE.

The company proposes to utilise the net proceeds from the fresh issue towards funding the working capital requirements, repayment of debt and general corporate purposes. JM Financial and Axis Capital are the book running lead managers to the issue.

Sresta Natural Bioproducts is engaged in the business of procuring, processing, manufacturing, marketing and research and development of organic food products.

Peers
Company Name CMP
Venkys India 1683.25
Mangalam Global Ent 13.82
Kaveri Seed 983.30
Regaal Resources 97.07
Simran Farms 169.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×